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A B S T R A C T
Background
Waterpipe tobacco smoking is a traditional method of tobacco use, especially in the Eastern Mediterranean Region (EMR), but its use
is now spreading worldwide. Recent epidemiological data, for example, show that waterpipe smoking has become the most prevalent
tobacco use method among adolescents in the EMR, and the second most prevalent in the US. Waterpipes are used socially, often
being shared between friends or family at home, or in dedicated bars and cafes that provide waterpipes to patrons. Because the smoke
passes through a reservoir of water, waterpipe tobacco smoking is perceived as being less harmful than other methods of tobacco use.
At least in some cultures, women and girls are more likely to use a waterpipe than to use other forms of tobacco, and it is popular
among younger smokers. Accumulating evidence suggests that some waterpipe smokers become addicted, have difficulty quitting, and
experience similar health risks as cigarette smokers.
Objectives
To evaluate the effectiveness of tobacco cessation interventions for waterpipe users.
Search methods
We searched theCochrane Tobacco Addiction ReviewGroup specialized register in June 2015. We also searchedMEDLINE, EMBASE,
PsycINFO and CINAHL , using variant terms and spellings (’waterpipe’ or ’narghile’ or ’arghile’ or ’shisha’ or ’goza’ or ’narkeela’
or ’hookah’ or ’hubble bubble’). We searched for trials, published or unpublished, in any language, and especially in regions where
waterpipe use is widespread.
Selection criteria
We sought randomized, quasi-randomized or cluster-randomized controlled trials of smoking cessation interventions for waterpipe
smokers of any age or gender. The primary outcome of interest was abstinence from tobacco use, measured at six months post-
cessation or longer, regardless of whether abstinence was biochemically verified. We included interventions that were pharmacological
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(for example, nicotine replacement therapy (NRT) or bupropion) or behavioural, or both, and could be directed at individual waterpipe
users or at groups of users. We only included tobacco cessation interventions, and did not consider trials of prevention of uptake.
Data collection and analysis
Two review authors assessed abstracts of the studies retrieved by the search strategy, for possible inclusion in the review. We retrieved full-
text articles for all abstracts that any of the authors believed might be suitable. Two review authors then extracted data and assessed trial
quality independently in accordance with standard Cochrane Collaboration methodologies. We aimed to pool groups of studies that
we considered to be sufficiently similar, provided there was no evidence of substantial statistical heterogeneity, and aimed to estimate a
pooled risk ratio (RR) using the Mantel-Haenszel fixed-effect method. Where meta-analysis was not possible, we presented summary
and descriptive statistics.
Main results
Our search retrieved 1311 unique citations, of which 1289 were excluded after title and abstract screening. Of the remaining 22, we
excluded 19 because they were empirical studies that were not randomized, quasi-randomized or cluster-randomized controlled trials
(n = 12), because they were review articles (n = 3), because they described protocols only (n = 2), they were conducted among cigarette
smokers only (n = 1), or they had only a three-month follow-up (n = 1).
We identified three controlled trials which tested cessation interventions for waterpipe smokers. Studies were carried out in Egypt
(Mohlman 2013), Pakistan (Dogar 2014), and the US (Lipkus 2011). One was a randomized controlled trial and two were cluster-
randomized trials. Two studies tested individual-level interventions, and one tested a community-level intervention. Two studies
included only behavioural interventions, and one study (Dogar 2014) included two intervention groups: one behavioural, and the
other behavioural with bupropion. The Lipkus and Mohlman studies delivered waterpipe-specific interventions, and the Dogar study
delivered a non-specific tobacco intervention. Due to study variation we did not pool results, and intervention effects are reported
descriptively. Compared to control groups, waterpipe smoking cessation rates were higher in the intervention groups in all three studies,
with a significant difference in two studies. For the Dogar study, the RRs for waterpipe smoking abstinence at 25 weeks among
waterpipe-only smokers were 2.2 (95% confidence interval (CI) 1.3 to 3.8; 180 participants) in the behavioural group, and 2.5 (95%
CI 1.3 to 4.7; 84 participants) in the behavioural plus bupropion group. In our analysis we have combined both groups, to give a RR
of 2.28 (95% CI 1.36 to 3.83; 200 participants). The Mohlman study delivered a RR in male waterpipe-smokers at one year in favour
of the intervention of 3.25 (95% CI 1.19 to 8.89).
Authors’ conclusions
Although the literature on waterpipe cessation interventions remains sparse, the reviewed studies provide a basis for developing
interventions in this area. The lack of statistically significant effects in one of the three studies is not unexpected, given the small and
pilot nature of the studies. The studies highlight important design and content issues that need to be considered for future cessation
trials in waterpipe smokers. These include building on the vast experience developed in the study of smoking cessation interventions
in cigarette smokers, whilst including components and assessment tools that address the specific aspects of waterpipe smoking, such as
its social dimension, unique experiences, and cues.
P L A I N L A N G U A G E S U M M A R Y
Can users of waterpipes be helped to quit through smoking cessation interventions?
Background
Waterpipe smoking is a traditional method of tobacco use, especially in the Eastern Mediterranean Region, but its use is now spreading
worldwide. It is smoked socially and often shared between friends or family at home, or in bars and cafes that provide waterpipes to
patrons. In the absence of relevant data, many waterpipe tobacco smokers believe this form of tobacco use is less lethal and addictive
than other methods of tobacco smoking, because the smoke passes through water on its way to the user. At least in some cultures,
women and girls are more likely to use a waterpipe than other forms of tobacco, and it is popular among younger smokers. Current
evidence suggests that waterpipe smoking may be as addictive as other forms of tobacco use, that some users have difficulty quitting
on their own and that they may experience similar risks to health as cigarette smokers.
Study characteristics
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We searched for controlled trials in the Cochrane Tobacco Addiction Review Group specialized register, in June 2015. We also searched
a number of electronic databases, including MEDLINE, EMBASE, PsycINFO and CINAHL, using a variety of names and spellings
for waterpipe use (’waterpipe’ or ’narghile’ or ’arghile’ or ’shisha’ or ’goza’ or ’narkeela’ or ’hookah’ or ’hubble bubble’). We searched
for published and unpublished trials in any language, and especially in areas where waterpipe use is widespread. We identified three
studies that tested behavioural methods to help waterpipe smokers to quit. Two were waterpipe-specific interventions and one was a
non-specific tobacco intervention.One small, pilot study was set in the USA, and delivered a Powerpoint presentation online to 91
college students who were using waterpipe. One study was a secondary analysis of data from 264 waterpipe smokers who were part of
a trial that enrolled people suspected of having tuberculosis from 33 healthcare clinics in Pakistan. Clinics were randomly assigned to
deliver a behavioural intervention versus control (usual care), or a behavioural intervention plus medication (bupropion) versus control
(usual care). The third study, set in Egypt, targeted both cigarette and waterpipe smokers, and was a community-based programme.
Key results
In all three trials, the percentage of participants who stopped smoking waterpipe was higher in the intervention groups than in the
control groups, although this was a statistically significant finding in only two of the trials. People who received either behavioural
treatment or behavioural treatment plus buproprion weremore likely to quit waterpipe smoking at six months follow-up than those who
received usual care.Men smoking waterpipe in the Egyptian study weremore likely to have quit at one year follow-up in the intervention
villages than in the control villages. These studies provide support to suggest that cessation interventions may help waterpipe smokers
to quit. However, further larger studies are needed to build on this.
Quality of the evidence
The trials were all rated at very low quality of evidence, as they were relatively small studies, with at least one high risk of bias.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Waterpipe intervention compared with a control for waterpipe cessation
Outcomes Impact Number of Participants
(Studies)
Certainty of the evi-
dence
(GRADE)*
Comments
Prolonged Cessation (Dogar 2014) RR 2.48
(95% CI: 1.36 to 3.83)
for 25 weeks cessat ion
(Lipkus 2011) RR 1.46
(95% CI: 0.81 to 2.62)
for 6 months
(Mohlman 2013) RR 3.
25 (95% CI: 1.19 to 2.
12) for 12 months ces-
sat ion
200 (1)
91 (1)
540 (1)
⊕©©©
very low
The studies were not
pooled as the interven-
t ions were not suf f i-
cient ly sim ilar in design
and part icipant demo-
graphics. There is no
pooled ef fect est imate
CI: Conf idence interval; RR: Risk Ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and
may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is
likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
* The certainty of the evidence was very low as all the studies had at least one high risk of bias in accordance with the
GRADE f ramework (see Figure 2).
B A C K G R O U N D
Estimates suggest that by 2030 there will be more than 10 million
tobacco-related deaths a year worldwide, with 70% of them oc-
curring in developing countries (Peto 2001). Patterns of tobacco
usage and uptake are of increasing concern, as the tobacco industry
concentrates its marketing in developing countries, paying partic-
ular attention to women and girls and to a wide range of tobacco
products (GYTS 2003).
One traditional method of smoking tobacco, especially in the
Eastern Mediterranean Region (EMR), is the waterpipe, in which
smoke passes through a reservoir of water before inhalation by the
smoker. The waterpipe, known as narjeela in formal Arabic, goes
by various local names such as shisha, narghile, arghile, and hookah
(Maziak 2004). Although waterpipe use was uncommon in most
of the world before the 1990s, it has enjoyed a recent resurgence,
and is now spreading into areas where there was no previous tra-
dition of use (Ward 2015). In most countries of the EMR, water-
pipe smoking has become the most common tobacco use method
among youth, and the trend is spreading to other world regions
such as the US, where waterpipe smoking became the secondmost
popular tobacco use method among college, high-, and middle-
school students (Arrazola 2015; Maziak 2015; Primack 2009).
While solitary waterpipe use is quite common, waterpipe use is
predominantly a social phenomenon, occurring among friends or
family, and often indedicated cafés andbars (Akl 2015;Martinasek
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2011).
It is hard to establish all of the potential factors responsible for the
global spread of an addictive behaviour such as waterpipe smoking.
An addictive behaviour will tend to spread gradually unless it is
countered by effective policies and regulations. It is believed that
the resurgence in the popularity of waterpipe was sparked by the
introduction of flavoured, sweetened tobacco calledMaassel in the
Middle East during the early 1990s, whilst the global economy,
advancements in communication and social media, emigration
and tourism have helped to spread the practice globally (Maziak
2015). The lack of effective policies to deal with this relatively new
trend is certainly contributing to the vacuum within which this
tobacco use method is allowed to thrive (Jawad 2015).
Many waterpipe smokers believe that waterpipe smoking is a
safer alternative to cigarettes; an apparent misperception given
the available evidence (Akl 2015; Asfar 2008; El-Zaatari 2015;
Martinasek 2011). This evidence demonstrates the wide-ranging
potential harm of waterpipe smoking, as well as its addictive na-
ture (Aboaziza 2015; El-Zaatari 2015; Shihadeh 2015). Many wa-
terpipe users become dependent, evidenced by urges to smoke wa-
terpipe and other withdrawal symptoms when they abstain, relief
of these symptoms when they smoke waterpipe, and difficulty in
quitting (Aboaziza 2015). Several studies have reported that be-
tween 25% and 64% of waterpipe users want to quit (Akl 2013;
Anjum 2008; Ward 2005) and that at least 25% make a quit at-
tempt in any given year (Anjum 2008; Ward 2005; Ward 2006).
Quit rates, however, are very low (Ward 2006).
The most identified behavioural association with waterpipe smok-
ing is cigarette smoking. Many studies from around the world
have documented the salience of cigarette smoking among wa-
terpipe smokers, and cigarette smoking has been shown to be a
major predictor of waterpipe smoking among youth. In the US
Monitoring the Future survey, waterpipe use among high-school
seniors was associated with current and former cigarette smoking
(Maziak 2015). Dual smoking, however, tends to decrease with
age, as older smokers are usually more loyal to a single tobacco
use method. For example, in a study alluded to earlier, compar-
ing novice with established waterpipe smokers in Syria, the preva-
lence of dual smoking was 47.7% for novice smokers compared
to 26.5% for established ones (Maziak 2015).
Given the global increase in waterpipe smoking, and evidence that
many users become dependent and have difficulty quitting on
their own, waterpipe-specific tobacco cessation interventions are
required. This review aims to summarize the evidence available
regarding smoking cessation interventions for waterpipe smokers.
O B J E C T I V E S
To evaluate the effectiveness of tobacco cessation interventions for
waterpipe users.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomized controlled trials, quasi-randomized controlled trials
and cluster-randomized controlled trials.
Types of participants
Current (past month) users of waterpipes for tobacco smoking, of
any age and either gender.
Types of interventions
We included interventions directed at waterpipe users that
were pharmacological (for example, nicotine replacement therapy
(NRT) or bupropion) or behavioural, or both. These could be
directed at individual users or groups of users. We only included
cessation interventions, and did not consider trials of prevention
of smoking uptake.
Types of outcome measures
The primary outcome was abstinence from any tobacco waterpipe
use for sixmonths ormore from the beginning of intervention.We
report abstinence at longest follow-up, and prefer the strictest def-
inition of abstinence (continuous or prolonged over point preva-
lence, as defined by Hughes 2003). We prefer biochemically-vali-
dated abstinence over self-reported abstinence.
Search methods for identification of studies
We searched the Cochrane Tobacco Addiction Review Group spe-
cialized register for trials, using the terms ’waterpipe’ or ’narghile’
or ’arghile’ or ’shisha’ or ’goza’ or ’narkeela’ or ’hookah’ or ’hubble
bubble’, plus variant spellings of these terms, and ’smoking’ in the
title or abstract, or as keywords. This register was developed from
electronic searching of MEDLINE, EMBASE and PsycINFO, to-
gether with handsearching of specialist journals, conference pro-
ceedings and reference lists of previous trials and overviews. We
also searched MEDLINE (1946 to present), EMBASE (1980 to
present), CINAHL (1981 to present) and PsycINFO (1806 to
present), using the above free-text terms combined with MeSH
or free-text smoking-related terms (smok* or tobacco or cigar*
or nicotine). We searched for trials, published or unpublished,
in any language, and especially in regions where waterpipe use is
widespread.We also used our existing bibliography, compiled from
earlier exhaustive reviews of the literature on waterpipe smoking
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(e.g. Aboaziza 2015; El-Zaatari 2015; Jawad 2015; Maziak 2004;
Maziak 2015; Shihadeh 2015). The most recent search was com-
pleted on 19th June 2015.
Data collection and analysis
Two review authors (MJ and SJ) assessed the abstracts of studies
retrieved by the search strategy, for possible inclusion in the review.
We retrieved full-text articles for all abstracts which either review
author believed might be suitable.
Assessment of full articles
Two review authors (MJ and SJ) assessed each full-text article in-
dependently, using the agreed inclusion criteria. Where there was
ambiguity in trial reporting or a lack of data, we contacted inves-
tigators for clarification where possible. If we could not retrieve
missing data we considered exclusion on that basis.
We rated the overall methodological quality of studies as being at
low, moderate, or high risk of bias for each of the following criteria
to assess risk of bias:
1. Random sequence generation
2. Concealment of allocation
3. Blinding of participants and personnel
4. Blinding of outcome assessment
5. Incomplete outcome data (attrition rates and losses to
follow-up)
6. Biochemical verification of smoking status
We maintained a full list of excluded studies.
Data collection
We extracted and reported the following information, where avail-
able, concerning each study:
• Country and study setting
• Dates study was conducted
• Theoretical framework (including a brief description of the
intervention)
• Focus of the intervention (e.g. any tobacco use, waterpipe
smoking)
• Type of intervention, its duration, intensity, delivery format
• Length of follow-up
• Number of participants or number of clusters and
participants
• Age range, socio-economic status, gender and ethnicity (if
relevant) of participants
• Definition of smoking status used (e.g. level of waterpipe
use, concurrent use of other tobacco)
• Definition of abstinence
• Biochemical validation (if present)
• Differential effects post-intervention relating to age, gender,
ethnicity and intensity of intervention
• Adverse effects of the intervention
• Sources of funding
We aimed to pool groups of studies that we considered to be suf-
ficiently similar in their interventions, comparison groups, setting
and participants, provided that there was no evidence of substan-
tial statistical heterogeneity as assessed by the I² statistic (Higgins
2003). We aimed to estimate a pooled risk ratio (RR) using the
Mantel-Haenszel fixed-effect method, based on the quit rates at
longest follow-up for trials with at least six months follow-up from
the start of the intervention. Where meta-analysis was not possi-
ble, we present a descriptive summary and descriptive statistics.
We include a glossary of tobacco-specific terms (Appendix 1) as
an additional table in this review.
R E S U L T S
Description of studies
Our search retrieved 1311 unique citations, of which 1289 were
excluded after title and abstract screening.Of the remaining 22, we
excluded 19 for the following reasons: they were non-randomized
studies (n = 12), review articles (n = 3), a protocol only (n = 2),
conducted among cigarette smokers only (n = 1), or had only a
three-month follow-up (n = 1). The flow of studies is illustrated
in Figure 1.
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Figure 1. Study flow diagram.
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We identified three eligible studies which tested cessation inter-
ventions for waterpipe smokers. One was a randomized controlled
trial (Lipkus 2011) and two were cluster-randomized trials (Dogar
2014; Mohlman 2013). Two were individual-level interventions
(Dogar 2014; Lipkus 2011) and one was a community-level inter-
vention (Mohlman 2013). Interventions were carried out in Egypt
(Mohlman 2013), Pakistan (Dogar 2014), and the US (Lipkus
2011). All interventions were behavioural interventions, although
one study included two intervention groups: one behavioural, and
the other behavioural with bupropion (Dogar 2014). One study
was based on a theoretical framework (Dogar 2014). Further char-
acteristics of included studies can be found in Characteristics of
included studies.
The first study took place in Pakistan between 2010 and 2011 and
was a three-arm, cluster-randomized non-inferiority trial among a
mix of cigarette-only smokers (n = 1181), waterpipe-only smokers
(n = 200) and mixed smokers (n = 460) (Dogar 2014). The three
arms were standard care (control group), a brief behavioural in-
tervention (BSS) and a brief behavioural intervention plus bupro-
pion for seven weeks (BSS+). The behavioural intervention was
adapted from evidence-based treatments used for cigarette smok-
ers and involved two structured sessions (the first 30 minutes long,
the second 10 minutes long) one week apart. It was delivered
by tuberculosis DOTS (directly observed treatment, short course)
paramedics. The bupropion regimen was 75 mg/day for the first
week and 150 mg/day for the next six weeks. The control group
received a leaflet with standard healthmessages about the harms of
tobacco. The clusters were primary and secondary healthcare cen-
tres registered as diagnostic centres by a tuberculosis programme.
The study authors adjusted for the effect of clustering by conduct-
ing a multi-level analysis. The study was funded by the Interna-
tional Development Research Centre, Canada.
The second study took place in the US between 2009 and 2010,
and was a randomized controlled web-based intervention among
waterpipe smoking college/university students (Lipkus 2011).
Ninety-one students were randomized to non-health-related in-
formation about waterpipe (control group) or to both non-health-
related and health-related information about waterpipe (interven-
tion group). The study was funded by grants from the US Na-
tional Cancer Institute and National Institute on Drug Abuse.
The final study took place in Egypt between 2004 and 2005, and
was a cluster-randomized controlled community-level interven-
tion (Mohlman 2013). The clusters were villages in the Qalyubia
governorate. Villages, with a total of 7657 participants, were ran-
domised to receive a behavioural intervention through a variety of
activities engaging school students, places of worship, and adult
women, and delivered by teachers, religious leaders and female
social-change agents respectively. Primary school students partook
in activities to prevent the initiation of tobacco use through its
deglamorisation and teaching of health effects. Preparatory and
secondary school students were taught social skills to handle peer
pressure to smoke. Religious communities were informed of the
health effects of tobacco use/secondhand smoke, and the sinful
nature of smoking. Adult women at home were taught about the
health effects of tobacco use/secondhand smoke and how to pro-
tect themselves and their children from it in a culture-specific way.
Control villages received no intervention but had access to Egypt’s
National Tobacco Control Program during the study. The study
authors adjusted for the effect of clustering in the analysis. The
study was funded by The Fogarty International Center of the US
National Institutes of Health.
Studies were not comparable in terms of participants’ smoking
status, intervention type, and outcome measures. For example,
participants in Dogar 2014 smoked a local form of unflavoured
waterpipe tobacco a median of 10 times per day, participants in
Mohlman 2013 smoked two to three times per day, and partici-
pants in Lipkus 2011 smoked flavoured Maassel monthly. With
regards to the delivery method of interventions, one study pro-
vided aweb-based intervention (Lipkus 2011), one provided group
intervention (Mohlman 2013), and one provided interventions
aimed at individuals (Dogar 2014). With regards to outcomes,
only one study (Dogar 2014) biochemically validated abstinence
by expired carbon monoxide (CO < 9 ppm), while the remain-
ing two trials relied on only self report of smoking status (Lipkus
2011;Mohlman 2013). Follow-up length ranged from six months
to one year post-intervention.
Risk of bias in included studies
We considered two studies (Dogar 2014; Lipkus 2011) to be at
low risk of bias for random sequence generation as they adequately
described a simple randomization process. Mohlman 2013 used a
randomized design but the details were not reported. We deemed
only one study to be at low risk of bias for adequate allocation
concealment (Dogar 2014) as it was concealed by a researcher
blinded to centre identity. The remaining two studies did not
provide information on allocation concealment (Lipkus 2011;
Mohlman 2013).We ratednone of the studies at low risk of bias for
blinding of participants and personnel; Dogar 2014 was an open-
label trial, while in Lipkus 2011 andMohlman 2013 blinding was
notmentioned. Althoughnone of the studies reported the presence
of blinding,we considered one study (Dogar 2014) to be at low risk
of bias for blinding of outcome assessment, as it was biochemically
verified with a carbon monoxide measurement of 9 ppm or less.
We rated all three at low risk of bias for completeness of data,
as missing data ranged from 7% (Dogar 2014) to 23% (Lipkus
2011). Mohlman 2013 excluded women from the dataset because
smoking prevalence was very low in this group. No studies were at
low risk of bias for selective reporting. In Dogar 2014 outcomes
at five weeks were not reported, whereas in Lipkus 2011 and
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Mohlman 2013 cessation datawere not reported using appropriate
effect estimates. A summary of the ’Risk of bias’ assessment for the
included studies can be found in Figure 2.
Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
Effects of interventions
See: Summary of findings for the main comparison
Due to the variation in studies outlined above, we did not pool
the results of studies using meta-analysis or conduct statistical tests
for heterogeneity. We report the intervention effects descriptively
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and present abstinence data for individual trials in Figure 3.
Figure 3. Forest plot of comparison: 1 Raw Data, outcome: 1.1 Prolonged Cessation.
For Dogar 2014 we considered the data provided by waterpipe
smokers only (n = 200). Compared to the control group, the risk
ratio (RR) of smoking abstinence at 25 weeks was 2.2 (95% CI
1.3 to 3.8) for the BSS group and 2.5 (95% CI 1.3 to 4.7) for the
BSS+ group. In Figure 3 we have combined the BSS and BSS+
groups to create a single intervention group.
For Lipkus 2011, when comparing the intervention to the control
group, the RR for waterpipe cessation at sixmonthswas 1.46 (95%
CI 0.81 to 2.62; n = 70).
For the third study (Mohlman 2013), the RR of waterpipe cessa-
tion at one year was 3.25 (95% CI 1.19 to 8.89; n = 540) for the
intervention group compared to the control group.
D I S C U S S I O N
Waterpipe use is a growing phenomenon associated with substan-
tial toxicant exposure, numerous health risks, and development
of dependence in a sizeable proportion of users (Aboaziza 2015;
El-Zaatari 2015;Maziak 2015; Shihadeh 2015). Despite these ad-
verse consequences, development and evaluation of cessation in-
terventions for the waterpipe are scarce. In our review, we found
only three studies which met our inclusion criteria, covering 831
participants, that have examined interventions to help waterpipe
users quit smoking. All three studies tested behavioural interven-
tions, and one study also included a combined behavioural/phar-
macological (bupropion) intervention group (Dogar 2014). Due
to lack of comparability across the three studies in terms of partici-
pants’ smoking status, intervention type, and outcome assessment,
we did not conduct statistical tests for heterogeneity and meta-
analysis, but present intervention effects descriptively. Two trials
were conducted among adults in the Middle East (Dogar 2014;
Mohlman 2013), and one study was conducted among young
adults in the US (Lipkus 2011). This should be considered for
the generalizability of findings from these studies. Compared to
control groups, smoking cessation rates were higher in the inter-
vention groups in all three studies; however, the difference was not
statistically significant in one study (Lipkus 2011). These find-
ings suggest that waterpipe smokers may be more likely to stop
smoking successfully when using a community or a tailored smok-
ing cessation intervention than usual care; however they should
be treated with caution due to the paucity and limitations of the
available data.
The lack of a statistically significant effect in the American trial
is not unexpected, given the small, pilot nature of the study.
A Cochrane review of individual behavioural interventions for
cigarette smoking cessation demonstrated an RR of 1.39 (95% CI
1.2 to 1.57) (Lancaster 2005). At least two of the studies (Dogar
2014; Lipkus 2011) were unlikely to have the power to detect a
comparable RR. Suboptimal length of follow-up (less than one
year) was another limitation for two of the three included studies,
aswell as a reliance on self-reported data in all but one study (Dogar
2014). Abstinence verification methods should also be suitable for
waterpipe smoking. Expired breath CO, which is good for the de-
tection of smoking in the past 24 hours only, may not accurately
verify abstinence in intermittent waterpipe smokers, but can be
used as a ’bogus pipeline’ (Asfar 2014;Murray 1987; Patrick 1994)
to encourage truthful reporting of abstinence violations among
intermittent users. The absence of standard definitions for water-
pipe smoking status for inclusion in the trials was also an issue
that affected comparability of the reviewed studies. For example,
two of the reviewed studies (Lipkus 2011; Mohlman 2013) re-
cruited current waterpipe smokers who smoked waterpipe in the
past month, and one study (Dogar 2014) recruited regular water-
pipe smokers who “smoke >= 1 waterpipe per day.” Cigarette ces-
sation trials typically enrol daily smokers and outcome evaluation
is often focused on whether participants have returned to daily
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smoking. We noted the same inconsistency for the definition and
verification of abstinence in the three studies. In Dogar 2014, the
primary outcome was continuous abstinence at six-month follow-
up, while in Lipkus 2011 abstinence was defined as reporting no
longer using waterpipe at the six-month follow-up, and finally, in
Mohlman 2013 abstinence was defined as not smoking waterpipe
in the last month before the 12-month follow-up. Not only are
these outcomes hard to compare, they are not consistent with the
relevant scientific recommendations for cessation trials and with
common patterns of waterpipe smoking. Because many waterpipe
smokers are cigarette smokers as well, cessation outcomes should
be standardised to allow comparison with the cigarette literature as
well as to accommodate waterpipe smokers’ usage patterns. For ex-
ample, the definition of prolonged abstinence defined as; no smok-
ing, not even a puff, after a grace period of two weeks after quit
date, and relapse as smoking at least once a week on two consecu-
tive weeks (SRNT 2002), are standard cigarette-based definitions
that would seem to be suitable for waterpipe.
Out of the three included studies, only one evaluated a combined
intervention (behavioural plus bupropion), and did not show any
apparent additional benefit of adding bupropion to behavioural
support in achieving cessation (Dogar 2014), although these two
conditions were not directly tested against one another. The effi-
cacy of other pharmacological cessation modalities such as nico-
tine replacement therapy (NRT) or varenicline, which have been
shown to be useful in dependent cigarette smokers, have not yet
been tested in waterpipe smokers. Given that some waterpipe
smokers exhibit signs and symptoms of dependence (Aboaziza
2015), pharmacotherapy may be useful during cessation. This can
be particularly relevant to highly quit-motivated dual waterpipe/
cigarette users (Ward 2014). However, individuals who are less de-
pendent, have smoked for shorter periods of times, and who cite
social stigma (e.g. family disapproval) as a reason to stop smoking
make up the majority of waterpipe smokers interested in quitting
(Borgan 2013; Ward 2005). These individuals may be less likely
to benefit from pharmacological treatments. Such considerations
require having some standard, waterpipe-specific measure of de-
pendence that allows for the variability in both individual smoking
habits and nicotine content of different waterpipe tobacco brands
to be captured in a standardizedmanner. A recently developed scale
(Lebanon Waterpipe Dependence Scale-11) to characterize water-
pipe dependence has shown that self-reported dependence level
correlates with measurements of nicotine metabolites in flavoured
waterpipe tobacco users (Salameh 2008). This measure was devel-
oped based on cigarette smoking instruments and without input
from waterpipe smokers, but could be the first step in accurately
measuring dependence among waterpipe smokers.
Offering behavioural support adapted from a validated cigarette-
smoking cessation programme could be a useful starting point for
waterpipe smokers who are interested in quitting. Of the three
studies reviewed, two offered behavioural interventions utilizing
similar strategies to those shown to be effective for cigarette smok-
ers (Lipkus 2011; Mohlman 2013). Process evaluation data from
one of our excluded studies (Asfar 2014) indicates that the meth-
ods they used, which were adapted from traditional smoking ces-
sation methods, were acceptable to waterpipe smokers. However,
such approaches will miss dealing with the strong social dimen-
sion of waterpipe use, as it shapes use patterns, cues for smoking,
and the attitudes and preferences of waterpipe smokers (Aboaziza
2015; Jawad 2013; Maziak 2015).
Risks associated with the social use of waterpipe, such as the po-
tential to contract infectious diseases through sharing the same
waterpipe and using it repeatedly without proper sanitation in
café settings, can also provide powerful drives for cessation. Fu-
ture cessation efforts should consider introducing and examining
new methods of cessation intervention, such as group smoking
cessation. Results from the process evaluation in Asfar 2014 indi-
cate that one-third of waterpipe smokers were interested in partic-
ipating in a group counselling intervention. As the social context
of waterpipe smoking frequently involves family members (Akl
2015; Maziak 2015), family-based cessation interventions could
also be a promising avenue to pursue (Asfar 2014).
Despite the fact that the waterpipe epidemic is most pronounced
among youth and young adults (such as college students), only
one of the three reviewed studies was conducted among college
students. The study provided preliminary evidence that minimally
intensive interventions delivered online to educate college water-
pipe smokers of the harm, addiction, and toxicant exposure asso-
ciated with waterpipe smoking can increase understanding of the
harms of waterpipe use, perceptions of risk, desire to quit, and
eventually cessation (Lipkus 2011). Utilizing youth-oriented tech-
nology such as smart phones, text messaging, social networks, or
multimedia may provide promising cessation approaches for this
at-risk population.
Although the small number and methodological limitations of
waterpipe cessation trials to date do not allow firm recommen-
dations to be made on the comparative efficacy of various cessa-
tion methods, they do provide a new evidence base on which to
build further. They highlight important design and content issues
that need to be considered for future cessation trials in waterpipe
smokers. These include building on the vast experience of cigarette
smoking cessation interventions whilst introducing intervention
components and assessment tools that address the specific aspects
of waterpipe smoking. It also highlights some of the challenges
of future waterpipe cessation trials that relate to their specific set-
up, usage patterns and context, and adaptability of cigarette-based
definitions and measures to the waterpipe.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
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• Waterpipe smoking is spreading globally, and carries
considerable health risks. Due to its addictive nature, waterpipe
users who want to quit find it difficult to do so. This review
suggests that waterpipe smokers may be more likely to stop
smoking successfully when using a smoking cessation
intervention than usual care, but this needs to be treated with
caution due to the paucity and limitations of the data. Relying
on behavioural cessation approaches from the cigarette literature
seems to be a good starting point, but these should be adapted to
the specific nature of waterpipe smoking as a predominantly
social and intermittent behaviour with prolonged sessions.
Adding a pharmacological agent (bupropion) did not seem to
have an additional benefit to behavioural support in achieving
cessation, again based on the limited data available.
Implications for research
• Standard definitions and assessments of waterpipe use,
dependence and cessation need to be adopted. For example,
including smokers with “regular” waterpipe use, defined as
smoking three or more waterpipes a week, in smoking cessation
trials, will allow smoking cessation efforts to focus on those most
in need (most dependent), and at the same time allow the use of
standard cigarette-based definitions and verification of
abstinence (e.g. prolonged abstinence; saliva cotinine). Since
cotinine offers a window of four to five days for detection of
nicotine exposure, less frequent waterpipe smoking/abstinence
can be hard to verify biochemically. Most of these definitions are
already developed and need to be adopted by waterpipe cessation
research (e.g. Jarvis 1988; SRNT 2002).
• As waterpipe cessation trials are still in their infancy, it will
be helpful to develop and adopt consistent standards for
reporting outcomes to facilitate comparing study results (e.g.
standard definition of regular smoker, definition of abstinence
including duration, self report, and cut-off point of various
biochemical verification procedures).
• Since many waterpipe smokers are cigarette smokers as well,
such measures need to be consistent with the cigarette literature
and at the same time accommodate waterpipe smokers’
intermittent usage patterns.
• Waterpipe dependence measures need to be developed and
adopted that can capture the common as well as unique (e.g.
social dimension) aspects of tobacco dependence in waterpipe
smokers.
• Efforts to develop and test behavioural strategies that fit the
unique features of waterpipe smoking (e.g. the social cues, and
intermittent usage patterns) and address waterpipe-specific
facilitators and barriers to quitting are much needed (Maziak
2015).
• Given how little is currently known about who will use
cessation treatment, which treatments they will use, and what
specific methods work, it is imperative that large-scale,
randomized controlled trials be conducted to rigorously test
behavioural, pharmacological and combined cessation
approaches.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Dogar 2014
Methods Year(s) of study: 2010 - 2011
Study design: 3-arm cluster-randomized controlled non-inferiority trial
Country: Pakistan
Region: Jhang and Sarghoda districts
Setting: 33 primary and secondary health centres
Theoretical framework: based on the World Health Organization’s ’5As Approach’
Participants Adults aged over 18 years with suspected tuberculosis (cough ≥ 3 weeks, of unknown
cause)
Excluded: those requiring hospitalization or urgent medical attention
Recruitment method: patients attending primary and secondary healthcare centres reg-
istered as diagnostic centres by a tuberculosis program in 2 Pakistani districts
33 clusters, 200 adults
Mean age 51.5 (SD 13.8), median household income USD 81.4 (IQR 69.8), 21%
women
Definition of smoking status: ≥ 1 waterpipe/day
Interventions Focus of intervention: any smoking use
Type of intervention: behavioural and pharmacological
Description of the intervention:
Control group: given a leaflet with standard health messages about the harms of tobacco
Intervention group 1: 2 brief behavioural support cessations (1st visit 30 mins, 2nd on
quit day 10 mins)
Intervention group 2: 2 brief behavioural support cessations (as above) plus bupropion
for 7 weeks (75 mg/day for 1st week, 150 mg/day for next 6 weeks)
Intervention delivered by: tuberculosisDOTS (directly observed treatment, short course)
paramedics
Outcomes Continuous waterpipe smoking abstinence
Length of follow-up: six months
Biochemical validation: CO verified (< 10 ppm)
Notes Differential effects post-intervention: none reported
Adverse effects of intervention: none reported
The study was funded by the International Development Research Centre, Canada
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Not mentioned in sufficient detail in this
paper; full trial methodology found in Sid-
diqi 2013:
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Dogar 2014 (Continued)
Quote: “a researcher who was blinded to
center identity used computer-generated
random-number lists to generate allocation
sequence”
Comment: probably done
Allocation concealment (selection bias) Low risk Not mentioned in sufficient detail in this
paper; full trial methodology found in Sid-
diqi 2013:
Quote: “a researcher who was blinded to
center identity used computer-generated
random-number lists to generate allocation
sequence”
Commment: probably done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not mentioned in this paper; full trial
methodology found in Siddiqi 2013:
Quote: “the lack of blinding also meant
that a degree of observer bias was possible”
Comment: probably not done
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Not mentioned in this paper; full trial
methodology found in Siddiqi 2013:
Quote: “the lack of blinding also meant
that a degree of observer bias was possible”
Comment: outcome measurement is bio-
chemically verified, and is unlikely to be af-
fected by blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Primary outcome data missing for 7.0% of
waterpipe-only smokers. Reasons for miss-
ing data unlikely to be related to true out-
come. No exclusions reported
Selective reporting (reporting bias) High risk Outcomes not reported at 5 weeks
Other bias Low risk Biochemical verification of outcome
Lipkus 2011
Methods Year(s) of study: 2009 - 2010
Study design: randomized controlled web-based behavioural intervention
Country: USA
Region: North Carolina
Setting: 6 college and university campuses
Theoretical framework: none reported
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Lipkus 2011 (Continued)
Participants Adults enrolled in a 4-year college or university course
Recruitment method: newspaper advertisements, flyers posted around campuses, Craig’s
list, campus-wide Listserv
91 adults
Mean age 20.4 (SD 2.0), 24.2% women, 76.7% white
Definition of smoking status: past-month waterpipe smoking
Interventions Focus of intervention: waterpipe smoking
Type of intervention: behavioural
Description of the intervention:
Control group: 8 MS PowerPoint slides on waterpipe mechanism of action, chemical
composition, and epidemiology; average length of intervention 3.6 minutes
Intervention group: 20MS PowerPoint slides on waterpipe mechanisms of action, chem-
ical composition, epidemiology, puff topography, toxicant exposure, and health out-
comes; average length of intervention 7.5 minutes
Intervention delivered by: online
Outcomes Ticking the survey item: “no longer smoking waterpipe”
Length of follow-up: 6 months
Biochemical validation: not present
Notes Differential effects post-intervention: none reported
Adverse effects of intervention: none reported
The study was funded by grants from the US National Cancer Institute and National
Institute on Drug Abuse
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “those who logged on were ran-
domized to either a control or an experi-
mental group with equal probability by our
program”
Comment: probably done
Allocation concealment (selection bias) Unclear risk No information on allocation concealment
Comment: insufficient confidence that al-
location concealment was adequate
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information on blinding
Comment: insufficient confidence that
blinding was adequate
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No information on blinding
Comment: outcomemeasurement not bio-
chemically verified.
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Lipkus 2011 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 23.1% of participants did not conduct the
6-month follow-up. Unlikely to be related
to outcome.No reasons given for loss to fol-
low-up. 1 participant in the 6-month fol-
low-up had missing data and was not anal-
ysed. No exclusions reported
Selective reporting (reporting bias) High risk Cessation data not appropriately presented
as effect estimates
Other bias High risk No biochemical verification of outcome
Mohlman 2013
Methods Year(s) of study: 2004 - 2005
Study design: cluster-randomized controlled behavioural intervention
Country: Egypt
Region: Qalyubia governorate
Setting: Villages
Theoretical framework: None reported
Participants All household members aged over 12 years old, although results pertain only to adult
men (n of women for self-reported smoking too small);
Waterpipe smokers: Intervention villages 250, control villages: 290
Recruitment method: Systematic approach of households
6 clusters, 7657 residents
Mean age 36.9, 41.8% illiterate, 87.3% employed, 55.3% women
Definition of smoking status: Past-month waterpipe smoking
Interventions Focus of intervention: cigarettes and/or waterpipe smoking
Type of intervention: behavioural
Description of the intervention:
educational approach for primary/preparatory/secondary school students, mosques and
churches, and key female social change agents (raedat refeyat)
Intervention delivered by: teachers, religious leaders, female social change agents
Control group: no intervention
Outcomes Waterpipe smoking prevalence
Length of follow-up: 12 months
Biochemical validation: not present
Notes Differential effects post-intervention: none reported
Adverse effects of intervention: none reported
The study was funded by the Fogarty International Center of the US National Institutes
of Health
Risk of bias
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Mohlman 2013 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “the remaining six villageswere ran-
domly allocated to either the control group
or the intervention group”
Comment: insufficient confidence that the
allocation sequence was genuinely ran-
domised
Allocation concealment (selection bias) Unclear risk No information on allocation sequence
Comment: insufficient confidence that al-
location concealment was adequate
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No information on blinding
Comment: insufficient confidence that
blinding was adequate
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No information on blinding
Comment: outcome measurement is not
biochemically verified
Incomplete outcome data (attrition bias)
All outcomes
Low risk 77.5% retention rate. Women excluded
due to very low self-reporting of tobacco
use. All completed pre-intervention sur-
vey but not all completed post-intervention
survey. No reasons given for loss to follow-
up
Selective reporting (reporting bias) High risk Cessation data not appropriately presented
as effect estimates
Other bias High risk No biochemical verification of outcome
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Asfar 2014 3-month follow up
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D A T A A N D A N A L Y S E S
Comparison 1. Intervention versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Prolonged Cessation 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
Analysis 1.1. Comparison 1 Intervention versus control, Outcome 1 Prolonged Cessation.
Review: Interventions for waterpipe smoking cessation
Comparison: 1 Intervention versus control
Outcome: 1 Prolonged Cessation
Study or subgroup Intervention Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Dogar 2014 (1) 63/136 13/64 2.28 [ 1.36, 3.83 ]
Lipkus 2011 18/37 11/33 1.46 [ 0.81, 2.62 ]
Mohlman 2013 14/250 5/290 3.25 [ 1.19, 8.89 ]
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours control Favours intervention
(1) Combined behavioural and (behavioural + bupropion) groups
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A P P E N D I C E S
Appendix 1. Glossary of tobacco-related terms
Term Definition
Abstinence A period of being quit, i.e. stopping the use of cigarettes or other tobacco products,
May be defined in various ways; see also:
point prevalence abstinence; prolonged abstinence; continuous/sustained abstinence
Biochemical verification Also called ’biochemical validation’ or ’biochemical confirmation’:
A procedure for checking a tobacco user’s report that he or she has not smoked or used
tobacco. It can be measured by testing levels of nicotine or cotinine or other chemicals
in blood, urine, or saliva, or by measuring levels of carbon monoxide in exhaled breath
or in blood
Bupropion A pharmaceutical drug originally developed as an antidepressant, but now also licensed
for smoking cessation; trade names Zyban, Wellbutrin (when prescribed as an antide-
pressant)
Carbon monoxide (CO) A colourless, odourless highly poisonous gas found in tobacco smoke and in the lungs
of people who have recently smoked, or (in smaller amounts) in people who have been
exposed to tobacco smoke. May be used for biochemical verification of abstinence
Cessation Also called ’quitting’.
The goal of treatment to help people achieve abstinence from smoking or other tobacco
use, also used to describe the process of changing the behaviour
Continuous abstinence Also called ’sustained abstinence’.
A measure of cessation often used in clinical trials involving avoidance of all tobacco
use since the quit day until the time the assessment is made. The definition occasionally
allows for lapses. This is the most rigorous measure of abstinence
’Cold Turkey’ Quitting abruptly, and/or quitting without behavioural or pharmaceutical support
Craving A very intense urge or desire [to smoke].
See: Shiffman et al ’Recommendations for the assessment of tobacco craving and with-
drawal in smoking cessation trials’
Nicotine & Tobacco Research 2004: 6(4): 599-614
Dopamine A neurotransmitter in the brain which regulates mood, attention, pleasure, reward,
motivation and movement
Efficacy Also called ’treatment effect’ or ’effect size’:
The difference in outcome between the experimental and control groups
Harm reduction Strategies to reduce harm caused by continued tobacco/nicotine use, such as reducing
the number of cigarettes smoked, or switching to different brands or products, e.g.
potentially reduced exposure products (PREPs), smokeless tobacco
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(Continued)
Lapse/slip Terms sometimes used for a return to tobacco use after a period of abstinence. A
lapse or slip might be defined as a puff or two on a cigarette. This may proceed to
relapse, or abstinence may be regained. Some definitions of continuous, sustained or
prolonged abstinence require complete abstinence, but some allow for a limited number
or duration of slips. People who lapse are very likely to relapse, but some treatments
may have their effect by helping people recover from a lapse
nAChR [neural nicotinic acetylcholine receptors]: Areas in the brain which are thought to
respond to nicotine, forming the basis of nicotine addiction by stimulating the overflow
of dopamine
Nicotine An alkaloid derived from tobacco, responsible for the psychoactive and addictive effects
of smoking
Nicotine Replacement Therapy (NRT) A smoking cessation treatment in which nicotine from tobacco is replaced for a limited
period by pharmaceutical nicotine. This reduces the craving and withdrawal experi-
enced during the initial period of abstinence while users are learning to be tobacco-free
The nicotine dose can be taken through the skin, using patches, by inhaling a spray, or
by mouth using gum or lozenges
Outcome Often used to describe the result being measured in trials that is of relevance to the
review. For example smoking cessation is the outcome used in reviews of ways to help
smokers quit. The exact outcome in terms of the definition of abstinence and the length
of time that has elapsed since the quit attempt was made may vary from trial to trial
Pharmacotherapy A treatment using pharmaceutical drugs, e.g. NRT, bupropion.
Point prevalence abstinence (PPA) A measure of cessation based on behaviour at a particular point in time, or during a
relatively brief specified period, e.g. 24 hours, 7 days. It may include a mixture of recent
and long-term quitters. cf. prolonged abstinence, continuous abstinence
Prolonged abstinence A measure of cessation which typically allows a ’grace period’ following the quit date
(usually of about two weeks), to allow for slips/lapses during the first few days when
the effect of treatment may still be emerging
Relapse A return to regular smoking after a period of abstinence.
Secondhand smoke Also called passive smoking or environmental tobacco smoke [ETS].
A mixture of smoke exhaled by smokers and smoke released from smouldering
cigarettes, cigars, pipes, bidis, etc. The smoke mixture contains gases and particulates,
including nicotine, carcinogens and toxins
Self-efficacy The belief that one will be able to change one’s behaviour, e.g. to quit smoking
SPC [Summary of Product Characteristics] Advice from the manufacturers of a drug, agreed with the relevant licensing authority,
to enable health professionals to prescribe and use the treatment safely and effectively
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Tapering A gradual decrease in dose at the end of treatment, as an alternative to abruptly stopping
treatment
Titration A technique of dosing at low levels at the beginning of treatment, and gradually in-
creasing to full dose over a few days, to allow the body to get used to the drug. It is
designed to limit side effects
Withdrawal A variety of behavioural, affective, cognitive and physiological symptoms, usually tran-
sient, which occur after use of an addictive drug is reduced or stopped.
See: Shiffman et al ’Recommendations for the assessment of tobacco craving and with-
drawal in smoking cessation trials’ .
Nicotine & Tobacco Research 2004: 6(4): 599-614
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